Journals / Turkish journal of nephrology (Online) / 2020 / Cilt: 29 - Sayı: 3

Acute Kidney Injury in SARS-CoV-2 Infected Critically Ill Patients

Pages
185–189
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

AKI developed in 75% of the patients.Conclusion: In this study we detected a high frequency of AKI in SARS-CoV2 infected patients hospitalized in the ICU.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The main objective of this study is to evaluate the frequency of acute kidney injury (AKI) in COVID-19 infected patients who are hospitalized in the intensive care unit (ICU).
📊
Key Findings & Data:Materials and Methods: This study was performed retrospectively on patients above 18 years of age who had a positive polymerase chain reaction (PCR), a typical chest computed tomography (CT) for COVID-19 disease.
💡
Conclusion & Impact:AKI developed in 75% of the patients.Conclusion: In this study we detected a high frequency of AKI in SARS-CoV2 infected patients hospitalized in the ICU.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The main objective of this study is to evaluate the frequency of acute kidney injury (AKI) in COVID-19 infected patients who are hospitalized in the intensive care unit (ICU). Materials and Methods: This study was performed retrospectively on patients above 18 years of age who had a positive polymerase chain reaction (PCR), a typical chest computed tomography (CT) for COVID-19 disease. The patients were hospitalized in the medical ICU and kidney disease improving global outcomes (KDIGO) criteria was used for AKI classification.Results: We included 16 patients. The median age was 75 years and 88% were male. The most common co-morbid diseases were hypertension (HT) (56%) and cardiovascular disease (CVD) (44%). The median acute physiology and chronic health evaluation II (APACHE II) and sequential organ failure assessment (SOFA) scores were 26 (19-32) and 7 (4-9) respectively. Patients median serum blood urea nitrogen (BUN) and creatinine levels were 27.8 (19.2-44.7) mg/dL, 1.32 (0.97-2.81) mg/dL respectively. According to the KDIGO classification: there was no AKI in 25% of the patients while, 19% stage 1, 12% stage 2 and 44% stage 3 AKI was observed. AKI developed in 75% of the patients.Conclusion: In this study we detected a high frequency of AKI in SARS-CoV2 infected patients hospitalized in the ICU.

🔖

Cite This Article

GÜNDOĞAN, K., TEMEL, Ş., KETENCİOĞLU, B., RABAH, B., TUTAR, N., SUNGUR, M. (2020). Acute Kidney Injury in SARS-CoV-2 Infected Critically Ill Patients. Turkish journal of nephrology (Online), Cilt: 29 - Sayı: 3, 185–189. https://ajindex.com/articles/374835

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Zheng Y, Sun LJ, Xu M, Pan J, Zhang YT, Fang XL, et al. Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in Hangzhou, China. J Zhejiang Univ Sci B 2020
  2. [Crossref] 2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet (London, England) 2020
  3. [Crossref] 3. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020
  4. [Crossref] 4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet (London, England) 2020
  5. [Crossref] 5. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. Jama 2020
  6. [Crossref] 6. Temel S, Gundogan K, Ulger B, Arican H, Bulut K, Sari A, et al. Characteristics and outcomes of patients infected with SARS-CoV-2 admitted to intensive care units: Erciyes University covid-19 center experience. Erciyes Med J. 2020. doi: 10.14744/etd.2020.00907. [Crossref] 7. Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents 2020 May 22. doi: 10.1016/j.ijantimicag.2020.106024. [Epub ahead of print]. [Crossref] 8. Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020 May 16. doi: 10.1016/j.kint.2020.05.006. [Epub ahead of print]. [Crossref] 9. Ng JJ, Luo Y, Phua K, Choong A. Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): A meta-analysis. J Infect. 2020 May 8. doi: 10.1016/j.jinf.2020.05.009. [Epub ahead of print]. [Crossref] 10. Fanelli V, Fiorentino M, Cantaluppi V, Gesualdo L, Stallone G, Ronco C, et al. Acute kidney injury in SARS-CoV-2 infected patients. Crit Care 2020
  7. [Crossref] 11. Rossi GM, Delsante M, Pilato FP, Gnetti L, Gabrielli L, Rossini G, et al. Kidney biopsy findings in a critically ill COVID-19 patient with dialysis-dependent acute kidney injury: A case against "SARS-CoV-2 nephropathy". Kidney Int Rep. 2020 May 17. doi: 10.1016/j. ekir.2020.05.005. [Epub ahead of